Variability of Two Metabolomic Platforms in CKD

BACKGROUND AND OBJECTIVES: Nontargeted metabolomics can measure thousands of low-molecular-weight biochemicals, but important gaps limit its utility for biomarker discovery in CKD. These include the need to characterize technical and intraperson analyte variation, to pool data across platforms, and...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Clin J Am Soc Nephrol
Main Authors: Rhee, Eugene P., Waikar, Sushrut S., Rebholz, Casey M., Zheng, Zihe, Perichon, Regis, Clish, Clary B., Evans, Anne M., Avila, Julian, Denburg, Michelle R., Anderson, Amanda Hyre, Vasan, Ramachandran S., Feldman, Harold I., Kimmel, Paul L., Coresh, Josef
Formato: Artigo
Idioma:Inglês
Publicado: American Society of Nephrology 2019
Assuntos:
Original Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6364529/
https://ncbi.nlm.nih.gov/pubmed/30573658
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.07070618
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares